QC-Ready Assays By Design

Analytical methods can become a hidden bottleneck in cell and gene therapy when early development choices fail to meet QC and regulatory expectations. A more effective approach starts with defining an Analytical Target Profile (ATP) upfront and aligning stakeholders across development, QC, and technology teams before lab work begins. Standardizing key assay parameters—from gating strategies to reagents and instrument setup—reduces variability and supports seamless tech transfer. Automated, site-agnostic workflows further improve reproducibility while cutting manual effort and validation rework. The result is faster IND readiness, stronger data packages, and fewer late-stage surprises, enabling teams to move with greater confidence and speed.

Discover how early analytical alignment can transform QC from a constraint into a competitive advantage.